Reassurance to patients on immunosuppressive medications

Data on the course of COVID-19 in patients with rheumatic conditions are still rare and limited to small numbers of cases. Patients with rheumatic diseases are concerned about the extent to which their condition increases the risk of a severe course and the impact of the intake of their immunosuppressants on this.

"There is considerable…

New shielding guidance

The government has updated its guidance for people who are shielding taking into account that COVID-19 disease levels are substantially lower now than when shielding was first introduced.

People who are shielding remain vulnerable and should continue to take precautions but can now leave their home if they wish, as long as they are able to…

Back to work guidance

Following the announcement issued about the next steps to help people return to work, guidance in now available. Although there is different advice from all four nations, the Department for Business, Energy & Industrial Strategy has issued the following material.

The guidance is to help employers, employees and the self-employed understand…

Vitamin D

During this extraordinary period as many of us are still self-isolating or working from home, there is a fear that we're not getting enough vitamin D.

Vitamin D is made in the skin by the action of sunlight and this is the main source of vitamin D for most people, so being stuck inside, we may be at risk of not getting enough. In 2016 Public…

Show More